Skip Navigation

News & Resources

 

Subscribe to NHLBI Press Releases
August 28, 2017

Media Availability: NHLBI scientists available to discuss research advances during National Sickle Cell Awareness Month in September

September is National Sickle Cell Awareness Month and experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss recent research advances and directions in sickle cell disease, a devastating genetic disease. Among the researchers available to speak to reporters is Dr. John Tisdale, whose work on stem cell transplantation was prominently featured in the Discovery documentary First in Human, which aired in August.

June 12, 2017

During Men’s Health Week, NHLBI scientists available to discuss research on men’s health

June 12-18 is National Men’s Health Week and experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss research findings related to some of the more serious medical challenges that disproportionately affect men—sleep apnea, excess belly fat, and high blood pressure. All are linked to an increased risk for heart disease. The good news is that men can take steps now to prevent these problems or detect and treat them early enough to act against heart disease.

Subscribe to NHLBI In The News
September 19, 2017 : JAMA

Researchers are reporting that a multipronged community intervention that targets low-income patients resulted in improved blood pressure control.  The study, which involved about 1,400 uninsured patients in Argentina with uncontrolled blood pressure, used multiple approaches to control hypertension including home blood pressure monitoring, physician care, and weekly text-messaging to promote healthy lifestyle changes. Over the course of 18 months, the group receiving the intervention had a greater decrease in systolic and diastolic blood pressure than patients who received the usual medical care.  The study, published in JAMA, is funded by NHLBI and NIGMS.  

Healio: Multicomponent intervention controls BP in low-income patients

Science Codex: Community intervention among low-income patients results in improved blood pressure control

September 15, 2017 : The Guardian

A NHLBI-funded study concluded that five to seven years of hormone replacement therapy does not shorten the lives of post-menopausal women due to increased risk of death from cardiovascular disease or cancer. The findings, published in the journal JAMA, come from a Women’s Health Initiative’s trial, which followed 27,000 women for 18 years.

The New York Times: Taking Hormones for Menopause Doesn’t Raise Early Death Risk

Los Angeles Times: Up to 7 years of hormone therapy is safe for postmenopausal women, new data show

TIME: Why Hormone Replacement Therapy May Be Safer Than You Think

The Seattle Times: Study shows hormone pills don’t shorten older women’s lives

Tech Times: Hormone Replacement Therapy Won’t Cause Early Death, Long-Term Study Finds

Huffington Post: Hormone Therapy Isn’t As Risky As Once Thought, New Study Finds

More coverage

September 27, 2017 to September 28, 2017
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodeling and inflammation, vascular remodeling and inflammation, and tissue engineering/genome editing/new technologies.
October 25, 2017 to October 26, 2017
This conference will bring together leading experts in the field to discuss cutting-edge research in five key areas of systems biology: single-cell epigenomics, imaging-based systems biology, quantitative and integrative proteomics, systems biology of metabolism and large-scale data integration.